Trials / Completed
CompletedNCT06614881
Dexmedetomidine Dosage for Postoperative Delirium and Cognitive Function in Elderly TKA Patients
Optimal Effective Dose of Dexmedetomidine on Postoperative Delirium and Cognitive Function of Elderly Patients Planned For TKA Surgery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 132 (actual)
- Sponsor
- Tanta University · Academic / Other
- Sex
- All
- Age
- 35 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the efficacy of dexmedetomidine in reducing the incidence of postoperative delirium and cognitive dysfunction in elderly patients undergoing total knee arthroplasty (TKA). The study will compare the outcomes of patients receiving dexmedetomidine to those receiving a standard anesthetic or sedative, focusing on factors such as patient characteristics, surgical duration, and postoperative care. The research will explore the potential neuroprotective effects of dexmedetomidine and its ability to mitigate the risks associated with anesthesia and surgery in vulnerable elderly populations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexmedetomidine Injection [Precedex] | Dexmedetomidine (Precedex, 100 µg/ml) was provided as an intravenous (IV) loading dose of 1 µg/kg over 10-min |
| DRUG | Dexmedetomidine in 0.9 % NaCl 1,000 Mcg/250 mL (4 Mcg/mL) INTRAVEN INFUSION BOTTLE (ML) | Dexmedetomidine infusions were prepared to provide 0.5 µg/kg/h |
| DRUG | Dexmedetomidine in 0.9 % NaCl 1,000 Mcg/250 mL (4 Mcg/mL) INTRAVEN INFUSION BOTTLE (ML) | Dexmedetomidine infusions were prepared to provide 0.7 µg/kg/h |
| DRUG | Dexmedetomidine in 0.9 % NaCl 1,000 Mcg/250 mL (4 Mcg/mL) INTRAVEN INFUSION BOTTLE (ML) | Dexmedetomidine infusions were prepared to provide 1.1 µg/kg/h |
| DRUG | Normal saline | loading dose of saline was injected 10-min before induction of anesthesia. |
Timeline
- Start date
- 2024-07-01
- Primary completion
- 2024-10-15
- Completion
- 2024-11-01
- First posted
- 2024-09-26
- Last updated
- 2024-11-26
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06614881. Inclusion in this directory is not an endorsement.